Table 1 Detailed search terms

AGE’s

“advanced glycosylation end products” (OR) “advanced glycosylation end products receptor (supplementary concept)” (OR) “advanced glycation end product(s)” (OR) “advanced glycation end product(s) receptor” (OR) “non-enzymatic glycation” (OR)“ non-enzymatic glycosylation” (OR) “glycotoxins”.

Motor function

“musculoskeletal physiological phenomena” (OR) ”muscle fatigue” (OR) “muscle strength” (OR) “muscle rigidity” (OR) “muscle tonus” (OR) “muscle stiffness” (OR) “mechanical stiffness” (OR) “rigidity” (OR) “ physical endurance” (OR) “postural balance” (OR) “balance” (OR) “posture” (OR) “postural control” (OR) “articular range of motion” (OR) “psychomotor performance” (OR) “motor activity” (OR) “motor skills” (OR) “motor skills disorders” (OR) “coordination” (OR) “motor coordination” (OR) “motor control” (OR) “eye-hand coordination” (OR) “fine motor” (OR) “fine motor skills” (OR) “neuromuscular manifestations” (OR) “gait” (OR)“gait disorders” (OR) “walking” (OR) “locomotion” (OR) “falls (accidental)” (OR) “mobility limitation” (OR) “physical mobility” (OR) “physical performance” (OR) “physical activity” (OR) “activities of daily living” (OR) ”motor function” (OR) “motor function decline” (OR) “mobility impairment” (OR) “functional decline” (OR) “motor inhibition” (OR) “inhibition of action” (OR) “interlimb” (OR) “interlimb coordination”.